The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1609-1617 , June 2010

Electron transport chain dysfunction in neonatal pressure-overload hypertrophy precedes cardiomyocyte apoptosis independent of oxidative stress

Received 4 February 2009 ,Revised 3 July 2009 ,Accepted 9 August 2009.

References 

  1. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Ann Rev Physiol. 2003;65:45–79
  2. Choi YH, Cowan DB, Moran AM, Colan SD, Stamm C, Takeuchi K, et al. Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium. J Thorac Cardiovasc Surg. 2009;137:1356–1362
  3. Friehs I, Barillas R, Vasilyev NV, Roy N, McGowan FX, del Nido PJ. Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart. Circulation. 2006;114(1 Suppl):I290–I295
  4. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093–1129
  5. Beer M, Seyfarth T, Sandstede J, Landschutz W, Lipke C, Kostler H, et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol. 2002;40:1267–1274
  6. Watanabe N, Zmijewski JW, Takabe W, Umezu-Goto M, Le Goffe C, Sekine A, et al. Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. Am J Pathol. 2006;168:1737–1748
  7. Tsutsui H, Ide T, Kinugawa S. Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid Redox Signaling. 2006;8:1737–1744
  8. Lee HC, Wei YH. Role of mitochondria in human aging. J Biomed Sci. 1997;4:319–326
  9. Sugden PH, Clerk A. Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes. Antioxid Redox Signaling. 2006;8:2111–2124
  10. Tu VC, Bahl JJ, Chen QM. Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. J Pharmacol Expl Ther. 2002;300:1101–1110
  11. Kumar D, Jugdutt BI. Apoptosis and oxidants in the heart. J Lab Clin Med. 2003;142:288–297
  12. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol. 2008;294:C460–C466
  13. Friehs I, Cao-Danh H, Nathan M, McGowan FX, del Nido PJ. Impaired insulin-signaling in hypertrophied hearts contributes to ischemic injury. Biochem Biophys Res Commun. 2005;331:15–22
  14. Moran AM, Friehs I, Takeuchi K, Stamm C, Hammer PE, McGowan FX, et al. Noninvasive serial evaluation of myocardial mechanics in pressure overload hypertrophy of rabbit myocardium. Herz. 2003;28:52–62
  15. Friehs I, Moran AM, Stamm C, Choi YH, Cowan DB, McGowan FX, et al. Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury. Ann Thorac Surg. 2004;77:2004–2010discussion 2011
  16. Rousou AJ, Ericsson M, Federman M, Levitsky S, McCully JD. Opening of mitochondrial KATP channels enhances cardioprotection through the modulation of mitochondrial matrix volume, calcium accumulation, and respiration. Am J Physiol. 2004;287:H1967–H1976
  17. Birch-Machin MA, Briggs HL, Saborido AA, Bindoff LA, Turnbull DM. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol. 1994;51:35–42
  18. In:  Ausubel FM,  Brent R,  Kingston RE,  Moore DD,  Seidman JG,  Smith JA, et al. editor. Short protocols in molecular biology. 5th ed. Hoboken: Wiley; 2002;
  19. Bache RJ, Zhang J, Murakami Y, Zhang Y, Cho YK, Merkle H, et al. Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy. Cardiovasc Res. 1999;42:616–626
  20. Ingwall JS. Energy metabolism in heart failure and remodelling. Cardiovasc Res. 2009;81:412–419
  21. Porcelli AM, Angelin A, Ghelli A, Mariani E, Martinuzzi A, Carelli V, et al. Respiratory complex I dysfunction due to mitochondrial DNA mutations shifts the voltage threshold for opening of the permeability transition pore toward resting levels. J Biol Chem. 2009;284:2045–2052
  22. Hirst J, Carroll J, Fearnley IM, Shannon RJ, Walker JE. The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim Biophys Acta. 2003;1604:135–150
  23. Rustin P, Rotig A. Inborn errors of complex II—unusual human mitochondrial diseases. Biochim Biophys Acta. 2002;1553:117–122
  24. Fontanesi F, Soto IC, Barrientos A. Cytochrome c oxidase biogenesis: new levels of regulation. IUBMB Life. 2008;60:557–568
  25. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell. 2007;129:111–122
  26. Balaban RS. Domestication of the cardiac mitochondrion for energy conversion. J Mol Cell Cardiol. 2009;46:832–841
  27. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell. 2006;23:607–618
  28. Li JM, Gall NP, Grieve DJ, Chen M, Shah AM. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension. 2002;40:477–484
  29. Loor G, Schumacker PT. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ. 2008;15:686–690
  30. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, et al. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol. 2005;46:2116–2124
  31. Friehs I, Barillas R, Roy N, Vasilyev NV, Martinez JF, McGowan FX, et al. Deferoxamine mediated activation of hypoxia inducible factor-1α (HIF-1α) upregulates target genes for protection of hypertrophied myocardium. Circulation. 2005;112(17):II-350

 Supported by grants from National Heart, Lung and Blood Institute HL-075430 (to I. Friehs) and HL-063095 (to P. J. del Nido), and HL-074734 and HL-0066186 (to F. X. McGowan). Dr Griffiths was supported by the Harvard–Longwood Research Training in Vascular Surgery: T32 HL 007734 to F. W. Logerfo.

 Disclosures: None.

PII: S0022-5223(09)01346-4

doi: 10.1016/j.jtcvs.2009.08.060

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1609-1617 , June 2010

Article Tools

* Image Usage & Resolution